Screening for atrial fibrillation (AF) using a wearable heart monitor for 2 weeks can identify older adults with this potentially dangerous abnormal heart rhythm, but does not prevent subsequent strokes, according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept).
Novo Nordisk ramps up legal case against compounding pharmacies selling ‘misbranded’ semaglutide
Novo Nordisk is taking another Florida pharmacy to court after allegedly finding impurities in its compounded drugs marketed as semaglutide, including one sample that was